University of Thessaly (UTH)
Ολική αρθροπλαστική γόνατος GENESIS II - OXINIUM: μελέτη μέσο- και μακροπρόθεσμης κλινικής και ακτινολογικής αποτελεσματικότητας, επιβίωσης και φθοράς πολυαιθυλενίου
Abstract
dc:descriptionTotal knee arthroplasty is one of the most popular and successful orthopaedic procedures. One of the most devastating complication that can occur is loosening of the implants, caused by the wear of the materials used. This can lead to the need for revision arthroplasty. Oxidised zirconium is a material that combines the favourable properties of both metals (durability) and ceramics (low friction) and is therefore believed that it can reduce wear when used in arthroplasties. The present study examined the long-term clinical outcome of a total knee arthroplasty in which the femoral component is made from oxidised zirconium (OXINIUMΤΜ, Smith & Nephew, Memphis, TN, USA). The study included 261 total knee arthroplasties performed in the University Hospital of Larissa in 245 patients suffering from osteoarthritis. The follow-up time was 10 – 15.5 years, while the median time was 12.3 years. There was a statistically significant improvement in every clinical score that was evaluated compared to the pre-operative values (p<0.001). Improvement continued until the 2nd or 3rd follow-up year, with a gradual deterioration thereafter. Nevertheless, the clinical outcome remained statistically improved compared to pre-operatively in every score evaluated until the end of the follow-up period (p<0.01). The clinical scores used were Knee Society Score, Oxford Knee Score, WOMAC, KOOS and EURO-QoL. 90.1% of patients stated that the procedure fulfilled their pre-operative expectations. Radiographic follow-up showed radiolucent lines with KSRES score >5 in only one patient. Follow-up of this patient revealed no further loosening, radiographically or clinically.Survival analysis showed that the 15-year survival of Genesis II-OXINIUM arthroplasty in the present study with aseptic loosening as an end-point was 98.8% (95% CI: 87.5% - 100.0%), while 15-year survival with revision for any reason as an end-point was 98.0% (95% CI: 86.6% - 100.0%). The 15-year survival with re-operation for any reason as an end-point was 95.6% (95% CI: 84.0% - 100.0%), while 15-year survival for the worst case scenario was 84.9% (95% CI: 73.6% - 92.2%). The overall finding of the present study is that the use of oxidised zirconium as the femoral component of a total knee arthroplasty – in this case, the Genesis II – OXINIUM (Smith & Nephew, Memphis, TN, USA) – has favourable long-term clinical and radiological outcomes, without many major complications. This is the longest and one of the largest series in literature regarding the clinical outcome of using oxidised zirconium in total knee arthroplasties. However, the present study was not designed, and therefore could not show whether this material is superior to the ones already in use. Further studies and follow-up of the patients that have been operated with the use of this material are needed in order to establish the role of oxidised zirconium in orthopaedics.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papasoulis, Efthymios
- Παπασούλης, Ευθύμιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46954